Rankings
▼
Calendar
RCKT Q3 2016 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$539M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-1.65
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$805,000
Balance Sheet
Total Assets
$140M
Total Liabilities
$55M
Stockholders' Equity
$85M
Cash & Equivalents
$83M
← FY 2016
All Quarters
Q4 2016 →
